DOJ Fraud and Health Care Enforcement: Latest Priorities, Trends, and Compliance Considerations

Jul
30
2026

Date: July 30, 2026

Time: 12:00PM - 1:00PM (EST)

While Department of Justice (DOJ) priorities and resources shift, health care organizations continue to face significant enforcement risk. Recent DOJ initiatives, including the creation of the National Fraud Enforcement Division and publication of a revised corporate self-disclosure framework, are complicating and intensifying compliance expectations.

Join a cross-disciplinary team from Mintz’s Health Care Enforcement and White Collar Defense Practices for a practical discussion of the Trump administration’s enforcement tactics and trends, areas of concentration, and steps companies should take now to assess and strengthen compliance readiness.

Discussion topics include:

  • DOJ health care fraud and False Claims Act (FCA) enforcement priorities for mid-year 2026, including the impact of DOJ’s fraud-enforcement structural reorganization
  • Priority risk areas, including Medicare Advantage, laboratories and diagnostic testing, telehealth, wound care, and referral-source arrangements
  • The growing role of data analytics and new whistleblowers incentives for qui tam filings
  • Novel FCA theories and trending enforcement areas
  • Practical compliance, audit, and disclosure considerations for health care organizations and investors

Who should attend: In-house legal, compliance, and audit professionals; health system and portfolio company executives; and private equity sponsors investing in health care.

Event Contact

Ania Mirek | [email protected]

Register for Event

Speakers

Karen Lovitch

Karen Lovitch

Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.
Eoin P. Beirne

Eoin P. Beirne

Eóin P. Beirne is Co-chair of Mintz’s White Collar Defense and Government Investigations Practice. He guides clients from a wide range of industries through federal and state investigations and enforcement proceedings.
Samantha P. Kingsbury

Samantha P. Kingsbury

Samantha advises clients on regulatory and enforcement matters. She has deep experience handling violations of the federal ant-kickback statute and FCA investigations for clinical laboratories and hospitals.
Nick A. LaPalme

Nick A. LaPalme

Nick A. LaPalme is an Associate at Mintz who focuses his practice on white collar defense, internal investigations, and complex commercial litigation matters. He works with clients across a variety of industries, including financial services.